Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PET/CT Imaging of Neuroinflammation in Alzheimer's and Related Dementias
NCT04786223Phase 2Enrolling by invitation
- Start
- Mar 2021
- Primary completion
- Mar 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of [11C]ER176 in Alzheimer's disease (AD), Lewy body dementia (LBD). Started Mar 2021; status: enrolling by invitation.
02
Drugs
[11C]ER176
03
Conditions
Alzheimer's disease (AD)Lewy body dementia (LBD)
Beyond the preview
Go deeper on NCT04786223.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04786223.